Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and…

By A. Pastore, V. Jurinovic, R. Kridel, E. Hoster, A. Staiger, M. Szczepanowski, C. Pott, Nadja Kopp, Mark A. Murakami, H. Horn and 25 more. The Lancet Oncology, 2015

671 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/ac3ee1b9b3eef6ab8830613b7f60bd6bfbd63050

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Swerdlow
2. E. Campo
3. S. Pileri
4. Elaine S. Jaffe
5. N. Harris
6. H. Stein
7. R. Advani
8. G. Salles

Citations in the corpus

• The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (2016, methodology): “A new prognostic model integrating gene mutations with clinical parameters has been proposed, but, although conceptually interesting, requires validation.(58) Whether mutational analysis should be performed routinely for diagnostic, prognostic, or therapeutic purposes and whether it should be integr”